SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Fabrizio Gardoni, Monica Di Luca, Targeting glutamatergic synapses in Parkinson's disease, Current Opinion in Pharmacology, 2015, 20, 24

    CrossRef

  2. 2
    Susan H. Fox, Jonathan M. Brotchie, Tom M. Johnston, Movement Disorders, 2015,

    CrossRef

  3. 3
    Andrew J. Flores, Mitchell J. Bartlett, Lisa Y. So, Nicholas D. Laude, Kate L. Parent, Michael L. Heien, Scott J. Sherman, Torsten Falk, Differential effects of the NMDA receptor antagonist MK-801 on dopamine receptor D1- and D2-induced abnormal involuntary movements in a preclinical model, Neuroscience Letters, 2014, 564, 48

    CrossRef

  4. 4
    Wai Kin D. Ko, Qin Li, Erwan Bezard, Effects of l-tryptophan on l-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque model of Parkinson's disease, Neuroscience Letters, 2014, 566, 72

    CrossRef

  5. 5
    M. Angela Cenci, Glutamatergic pathways as a target for the treatment of dyskinesias in Parkinson's disease, Biochemical Society Transactions, 2014, 42, 2, 600

    CrossRef

  6. 6
    Nicolas Morin, Vincent A. Jourdain, Thérèse Di Paolo, Modeling dyskinesia in animal models of Parkinson disease, Experimental Neurology, 2014, 256, 105

    CrossRef

  7. 7
    Zsófia Majláth, László Vécsei, NMDA antagonists as Parkinson’s disease therapy: disseminating the evidence, Neurodegenerative Disease Management, 2014, 4, 1, 23

    CrossRef

  8. 8
    Christopher Kobylecki, David J. Burn, Lewis Kass-Iliyya, Mark W. Kellett, Alan R. Crossman, Monty A. Silverdale, Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease, Parkinsonism & Related Disorders, 2014, 20, 4, 452

    CrossRef

  9. 9
    Maryka Quik, Danhui Zhang, Xiomara A. Perez, Tanuja Bordia, Role for the nicotinic cholinergic system in movement disorders; therapeutic implications, Pharmacology & Therapeutics, 2014, 144, 1, 50

    CrossRef

  10. 10
    H. Iderberg, V. Francardo, E.Y. Pioli, Animal models of l-DOPA–induced dyskinesia: an update on the current options, Neuroscience, 2012, 211, 13

    CrossRef

  11. 11
    Secundino López-Pousa, Oriol Turró-Garriga, Laia Calvó-Perxas, Olga Carmona, Jordi Gich, Elisabet Alsina, Fabià Màrquez, Marta Viñas, Josefa Turbau, Joan Vilalta-Franch, Anna Maria Roig, Josep Garre-Olmo, Consumption of Pharmaceuticals in Primary Non-Alzheimer’s Degenerative Dementias, Drugs & Aging, 2012, 29, 9, 733

    CrossRef

  12. 12
    Véronique Sgambato-Faure, Maria Angela Cenci, Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease, Progress in Neurobiology, 2012, 96, 1, 69

    CrossRef